|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
DE3586314D1
(de)
*
|
1984-11-27 |
1992-08-13 |
Behringwerke Ag |
Bifunktionelle haptene, verfahren zu ihrer herstellung und ihre verwendung.
|
|
US4804663A
(en)
|
1985-03-27 |
1989-02-14 |
Janssen Pharmaceutica N.V. |
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
|
US5576195A
(en)
|
1985-11-01 |
1996-11-19 |
Xoma Corporation |
Vectors with pectate lyase signal sequence
|
|
US6893625B1
(en)
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
|
ES2150428T3
(es)
|
1987-04-27 |
2000-12-01 |
Unilever Nv |
Ensayos de union especifica.
|
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
|
JPH02111798A
(ja)
*
|
1988-10-20 |
1990-04-24 |
Fuji Photo Film Co Ltd |
蛋白質修飾物
|
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
|
EP0517327B1
(en)
|
1991-06-07 |
2001-08-16 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Immunoassay with labeled hapten analogues
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
|
ES2153373T3
(es)
|
1992-05-29 |
2001-03-01 |
Lilly Co Eli |
Derivados de tienobenzodiazepina para el tratamiento de trastornos del sistema nervioso central.
|
|
DE69323244T2
(de)
|
1992-06-26 |
1999-07-08 |
Johnson & Johnson Clinical Diagnostics, Inc., Rochester, N.Y. |
Immunotests unter Verwendung von markierten Thyronin-Analogen
|
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
|
AU694147B2
(en)
|
1993-11-19 |
1998-07-16 |
Alkermes, Inc. |
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
|
AU710106B2
(en)
|
1994-06-10 |
1999-09-16 |
Oklahoma Medical Research Foundation |
Calcium binding recombinant antibody against protein c
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
|
US6139800A
(en)
|
1997-06-23 |
2000-10-31 |
Luminex Corporation |
Interlaced lasers for multiple fluorescence measurement
|
|
JPH1151935A
(ja)
*
|
1997-08-06 |
1999-02-26 |
Aisin Seiki Co Ltd |
複数種類のターゲット分子の同時検出方法
|
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
|
US20030143233A1
(en)
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
RU2181297C2
(ru)
*
|
2000-06-20 |
2002-04-20 |
Эпштейн Олег Ильич |
Способ лечения патологического синдрома и лекарственное средство
|
|
US7288390B2
(en)
*
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
|
US7163681B2
(en)
*
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
|
DE60335428D1
(de)
*
|
2002-01-31 |
2011-02-03 |
Randox Lab Ltd |
Immunogene, Antikörper und Konjugate für Ketamin und dessen Metaboliten
|
|
CN1646161A
(zh)
|
2002-02-21 |
2005-07-27 |
杜克大学 |
自身免疫疾病的药剂和治疗方法
|
|
EP2316469A1
(en)
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Delivery system and methods for protecting and administering dextroamphetamine
|
|
JP2005533009A
(ja)
|
2002-03-28 |
2005-11-04 |
イーライ・リリー・アンド・カンパニー |
ピペラジン置換されたアリールベンゾジアゼピン類およびそのドーパミン受容体アンタゴニストとしての精神病性障害の処置のための使用
|
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
|
CA2494109A1
(en)
|
2002-07-29 |
2004-02-05 |
Potomac, Pharma, Llc. |
Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic
|
|
AU2003264915A1
(en)
|
2002-08-05 |
2004-02-25 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines
|
|
US20040193446A1
(en)
|
2003-03-27 |
2004-09-30 |
Mayer Steven Lloyd |
System and method for managing a patient treatment program including a prescribed drug regimen
|
|
US7271252B2
(en)
|
2003-04-22 |
2007-09-18 |
Roche Diagnostics Operations, Inc. |
Reagents for detecting efavirenz
|
|
NZ543960A
(en)
|
2003-05-09 |
2008-11-28 |
Univ Duke |
CD20-specific antibodies and methods of employing same
|
|
CA2536073A1
(en)
*
|
2003-08-18 |
2005-02-24 |
H. Lundbeck A/S |
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
|
|
PT1664007E
(pt)
|
2003-09-23 |
2010-02-15 |
Fermion Oy |
Preparação de quetiapina
|
|
BRPI0415165A
(pt)
|
2003-10-01 |
2007-01-09 |
Adolor Corp |
composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem
|
|
CA2543242C
(en)
|
2003-10-23 |
2015-04-14 |
Otsuka Pharmaceutical Co., Ltd. |
Controlled release sterile freeze-dried aripiprazole formulation and injectable formulation thereof
|
|
WO2005059547A2
(en)
*
|
2003-12-12 |
2005-06-30 |
Inverness Medical Switzerland Gmbh |
Assay
|
|
GB0328892D0
(en)
*
|
2003-12-12 |
2004-01-14 |
Inverness Medical Switzerland |
Positive signal assay for analytes
|
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
|
JP2005292087A
(ja)
*
|
2004-04-05 |
2005-10-20 |
Shionogi & Co Ltd |
５’−デオキシ−５’−メチルチオアデノシンに対する抗体
|
|
WO2005103250A1
(ja)
|
2004-04-26 |
2005-11-03 |
Takami Matsuyama |
葉酸リセプターベータ（FR-β）に対する単クローン抗体を含有する治療薬
|
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
US20060235005A1
(en)
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
|
US20080214808A1
(en)
|
2005-04-25 |
2008-09-04 |
Thomas Frederik Ernestine Spittaels |
Preparation of Aseptic 3-[2-[4-((6-Fluoro-1,2-Benzisoxazol-3-Yl)-1-Piperidinyl]-6,7,8,9-Tetrahydro-9-Hydroxy-2-Methyl-4H-Pyrido[1,2-a]Pyrimidin-4-One Palmitate Ester
|
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
|
SE528233C2
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
|
US20100061933A1
(en)
|
2006-10-20 |
2010-03-11 |
Naoki Kimura |
Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
|
|
US8975374B2
(en)
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
|
EP2077860B1
(en)
|
2006-10-25 |
2014-04-09 |
Ramot at Tel-Aviv University Ltd |
Psychotropic agents having glutamate nmda activity
|
|
US20080138842A1
(en)
*
|
2006-12-11 |
2008-06-12 |
Hans Boehringer |
Indirect lateral flow sandwich assay
|
|
AU2007332473B2
(en)
|
2006-12-14 |
2012-09-27 |
Forerunner Pharma Research Co., Ltd. |
Anti-Claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same
|
|
WO2008082979A2
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Diagnostic test for the detection of a molecule or drug in whole blood
|
|
US8071767B2
(en)
|
2007-01-08 |
2011-12-06 |
Actavis Group Ptc Ehf |
Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one hydrochloride
|
|
CN101245065B
(zh)
|
2007-02-14 |
2010-05-19 |
江苏恩华药业股份有限公司 |
制备苯并异噁唑衍生物的方法及其中间体
|
|
AU2008303540B2
(en)
|
2007-09-27 |
2012-04-26 |
Novartis Ag |
Drug monitoring assay
|
|
US8133743B2
(en)
|
2007-10-19 |
2012-03-13 |
Roche Diagnostics Operations, Inc. |
Phenobarbital derivatives useful in immunoassay
|
|
US10539580B2
(en)
*
|
2008-04-29 |
2020-01-21 |
Psychemedics Corporation |
Solid phase multi-analyte assay
|
|
JP5828762B2
(ja)
|
2008-07-21 |
2015-12-09 |
プロビオドルグ エージー |
診断用抗体アッセイ
|
|
MX2011001384A
(es)
*
|
2008-08-06 |
2011-09-27 |
Gosforth Ct Holdings Pty Ltd |
Composiciones y metodos para tratar trastornos psiquiatricos.
|
|
WO2010033270A1
(en)
|
2008-09-17 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
|
EP2350077B1
(en)
|
2008-10-14 |
2016-01-27 |
Entasis Therapeutics Limited |
Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
|
|
EP2347015A4
(en)
*
|
2008-10-29 |
2012-12-19 |
Janssen Pharmaceutica Nv |
METHOD FOR THE TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA BASED ON POLYMORPHISMS IN THE ERBB4 GEN
|
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
|
AU2010206376B2
(en)
*
|
2009-01-26 |
2012-10-18 |
Egalet Ltd. |
Controlled release formulations with continuous efficacy
|
|
JP2012520073A
(ja)
|
2009-03-10 |
2012-09-06 |
ベイラー リサーチ インスティテュート |
抗原提示細胞ターゲティングワクチン
|
|
AU2010266040B2
(en)
|
2009-06-25 |
2015-01-15 |
Alkermes Pharma Ireland Limited |
Prodrugs of NH-acidic compounds
|
|
KR101770844B1
(ko)
|
2009-07-31 |
2017-08-23 |
아센디스 파마 에이에스 |
폴리에틸렌 글리콜 기반의 생분해성 수불용성 하이드로겔
|
|
CA2771436A1
(en)
|
2009-08-17 |
2011-02-24 |
Forerunner Pharma Research Co., Ltd. |
Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
|
|
US8076097B2
(en)
|
2009-08-19 |
2011-12-13 |
Saladax Biomedical Inc. |
Imatinib immunoassay
|
|
EP2485767A1
(en)
|
2009-10-06 |
2012-08-15 |
Ascendis Pharma A/S |
Carrier linked paliperidone prodrugs
|
|
EP2343296A1
(en)
|
2009-12-01 |
2011-07-13 |
Chemo Ibérica, S.A. |
A process for the purification of paliperidone
|
|
EP2519101B1
(en)
|
2009-12-31 |
2015-08-19 |
Kempharm, Inc. |
Amino acid conjugates of quetiapine, process for making and using the same
|
|
SI2544536T1
(sl)
|
2010-03-11 |
2019-03-29 |
Kempharm, Inc. |
Maščobno kislinski konjugati kvetiapina proces za njih izdelavo in uporabo
|
|
US8114621B2
(en)
|
2010-03-12 |
2012-02-14 |
Saladax Biomedical Inc. |
Lenalidomide and thalidomide immunoassays
|
|
US8088594B2
(en)
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
|
WO2011159537A2
(en)
*
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Method and device for analyte detection
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
EP2585066B1
(en)
|
2010-06-24 |
2018-09-26 |
Alkermes Pharma Ireland Limited |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
WO2012003418A2
(en)
|
2010-07-02 |
2012-01-05 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine d2 receptors
|
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
|
CN102276592B
(zh)
|
2011-06-17 |
2013-10-16 |
大连理工大学 |
一种奥氮平有关物质及其制备方法、分析方法
|
|
CN102276624B
(zh)
|
2011-06-17 |
2013-10-16 |
大连理工大学 |
一种奥氮平有关物质及其制备方法和高效液相色谱分析方法
|
|
US20140243254A1
(en)
|
2011-08-12 |
2014-08-28 |
Ascendis Pharma A/S |
Polymeric Hyperbranched Carrier-Linked Prodrugs
|
|
WO2013024047A1
(en)
|
2011-08-12 |
2013-02-21 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
|
WO2013088255A1
(en)
|
2011-12-15 |
2013-06-20 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
|
WO2014028800A1
(en)
|
2012-08-16 |
2014-02-20 |
Janssen Pharmaceutica Nv |
Substituted pyrazoles as n-type calcium channel blockers
|
|
PT3321254T
(pt)
|
2012-08-21 |
2020-10-20 |
Janssen Pharmaceutica Nv |
Haptenos de aripiprazol e seu uso em imunoensaios
|
|
PL2888263T3
(pl)
*
|
2012-08-21 |
2018-10-31 |
Janssen Pharmaceutica Nv |
Hapteny rysperydonu i paliperydonu
|
|
CN104736564B
(zh)
|
2012-08-21 |
2019-02-05 |
詹森药业有限公司 |
喹硫平半抗原的抗体及其用途
|
|
EP2888277A4
(en)
*
|
2012-08-21 |
2016-05-18 |
Ortho Clinical Diagnostics Inc |
ANTIBODIES AGAINST PALIPERIDONE AND USE THEREOF
|
|
PT2888593T
(pt)
|
2012-08-21 |
2018-12-12 |
Janssen Pharmaceutica Nv |
Anticorpos contra risperidona e utilizações dos mesmos
|
|
WO2014031662A2
(en)
|
2012-08-21 |
2014-02-27 |
Ortho-Clinical Diagnostics, Inc |
Antibodies to olanzapine and use thereof
|
|
ES2701062T3
(es)
|
2012-08-21 |
2019-02-20 |
Janssen Pharmaceutica Nv |
Haptenos de olanzapina
|
|
CA2882595C
(en)
|
2012-08-21 |
2019-06-04 |
Ortho-Clinical Diagnostics, Inc. |
Antibodies to olanzapine haptens and use thereof
|
|
PL2888257T3
(pl)
|
2012-08-21 |
2018-02-28 |
Janssen Pharmaceutica Nv |
Hapteny kwetiapiny do zastosowania w testach immunologicznych
|
|
PT2888284T
(pt)
|
2012-08-21 |
2022-11-18 |
Janssen Pharmaceutica Nv |
Anticorpos dirigidos contra haptenos de risperidona e a sua utilização
|
|
JP6270845B2
(ja)
|
2012-08-21 |
2018-01-31 |
ヤンセン ファーマシューティカ エヌ．ベー． |
アリピプラゾールに対する抗体及びその使用
|
|
CN110054694B
(zh)
|
2012-08-21 |
2024-02-20 |
詹森药业有限公司 |
阿立哌唑半抗原的抗体及其用途
|
|
CA2882489A1
(en)
*
|
2012-08-21 |
2014-02-27 |
Ortho-Clinical Diagnostics, Inc. |
Antibodies to paliperidone haptens and use thereof
|
|
PL2888592T3
(pl)
|
2012-08-21 |
2018-03-30 |
Janssen Pharmaceutica Nv |
Przeciwciała względem kwetiapiny i ich zastosowania
|
|
PL2888258T3
(pl)
*
|
2012-08-21 |
2019-10-31 |
Janssen Pharmaceutica Nv |
Hapteny paliperydonu
|
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
|
WO2017106501A1
(en)
|
2015-12-17 |
2017-06-22 |
Janssen Pharmaceutica Nv |
Antibodies to risperidone and use thereof
|